KinomeMETA:一个网络平台,用于用meta-learning进行基因组范围的多药理学分析
Zhaojun Li1,2, Ning Qu3,4, Jingyi Zhou5,6,3
1College of Computer and Information Engineering, Dezhou University, Dezhou City 253023, China.
Nucleic acids research
|May 16, 2024
概括
KinomeMETA是一个新的AI平台,可以预测661个激酶的小分子效应. 它使用meta-learning快速分析药物标,帮助开发新的激酶抑制剂.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 激酶抑制剂是有前途的治疗方法,但全面的分析是昂贵的,现有的计算方法与研究不足的激酶作斗争.
- 多位抑制剂提供更广泛的疗效,但需要仔细的多药理学评估.
- 准确预测全基因组活性对于有效的药物开发至关重要.
研究的目的:
- 介绍KinomeMETA,一个人工智能驱动的网络平台,用于在基因组中可扩展地预测小分子多药学.
- 扩大计算激酶分析的范围和准确性,特别是对未经研究的激酶.
- 为研究人员提供可定制的工具,以提高激酶抑制剂的发现.
主要方法:
- 开发了一种新的元学习算法,以有效利用稀疏的活动数据.
- 集成的人工智能,使新的酶预测任务能够快速泛化.
- 扩大了对661个野生类型和突变性激酶的预测能力.
主要成果:
- 与现有的方法相比,KinomeMETA显著扩大了精确可预测的激酶的数量.
- 该平台在预测多药物效应方面展示了可扩展性和效率.
- 案例研究表明,KinomeMETA通过适应小数据集来发现新型活性化合物的能力.
结论:
- KinomeMETA提供了增强的kinome虚拟分析,克服了当前计算方法的局限性.
- 这种由人工智能驱动的平台是开发新的激酶抑制剂和推进激酶研究的宝贵工具.
- KinomeMETA是免费访问的,促进科学界更广泛的采用.
更多相关视频
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
548
11:19Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
Published on: November 17, 2019
16.1K
相关概念视频
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Pharmacokinetic Models: Overview
665
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
665
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
